XML 39 R27.htm IDEA: XBRL DOCUMENT
v3.25.3

Insider Trading Arrangements | 3 Months Ended
--- | ---
Sep. 30, 2025 shares
Trading Arrangements, by Individual |
Non-Rule 10b5-1 Arrangement Adopted | false
Rule 10b5-1 Arrangement Terminated | false
Non-Rule 10b5-1 Arrangement Terminated | false
Herve Hoppenot [Member] |
Trading Arrangements, by Individual |
Material Terms of Trading Arrangement | Hervé Hoppenot, a director and the Special Advisor to the Chief Executive Officer, adopted a trading plan on August 11, 2025 providing for the sale of up to an aggregate of 187,500 shares of our common stock until August 11, 2026.
Name | Hervé Hoppenot
Title | director and the Special Advisor to the Chief Executive Officer
Rule 10b5-1 Arrangement Adopted | true
Adoption Date | August 11, 2025
Expiration Date | August 11, 2026
Arrangement Duration | 365 days
Aggregate Available | 187,500
Steven Stein [Member] |
Trading Arrangements, by Individual |
Material Terms of Trading Arrangement | Steven Stein, our Executive Vice President and Chief Medical Officer, adopted a trading plan on August 6, 2025 providing for the sale of up to an aggregate of 69,435 shares of our common stock until August 6, 2026.
Name | Steven Stein
Title | Executive Vice President and Chief Medical Officer
Rule 10b5-1 Arrangement Adopted | true
Adoption Date | August 6, 2025
Expiration Date | August 6, 2026
Arrangement Duration | 365 days
Aggregate Available | 69,435
Lee Heeson [Member] |
Trading Arrangements, by Individual |
Material Terms of Trading Arrangement | Lee Heeson, our Executive Vice President and Head of Incyte International, adopted a trading plan on August 4, 2025 providing for the sale of up to an aggregate of 3,074 shares of our common stock until August 4, 2026.
Name | Lee Heeson
Title | Executive Vice President and Head of Incyte International
Rule 10b5-1 Arrangement Adopted | true
Adoption Date | August 4, 2025
Expiration Date | August 4, 2026
Arrangement Duration | 365 days
Aggregate Available | 3,074
Thomas Tray [Member] |
Trading Arrangements, by Individual |
Material Terms of Trading Arrangement | Thomas Tray, our Vice President, Chief Accounting Officer, adopted a trading plan on August 22, 2025 providing for the sale of up to an aggregate of 4,143 shares of our common stock until August 24, 2026.
Name | Thomas Tray
Title | Vice President, Chief Accounting Officer
Rule 10b5-1 Arrangement Adopted | true
Adoption Date | August 22, 2025
Expiration Date | August 24, 2026
Arrangement Duration | 367 days
Aggregate Available | 4,143
Patrick Mayes [Member] |
Trading Arrangements, by Individual |
Material Terms of Trading Arrangement | Patrick Mayes, our Executive Vice President, Chief Scientific Officer, adopted a trading plan on September 8, 2025 providing for the sale of up to an aggregate of 5,750 shares of our common stock until September 8, 2026.
Name | Patrick Mayes
Title | Executive Vice President, Chief Scientific Officer
Rule 10b5-1 Arrangement Adopted | true
Adoption Date | September 8, 2025
Expiration Date | September 8, 2026
Arrangement Duration | 365 days
Aggregate Available | 5,750
Michael Morrissey [Member] |
Trading Arrangements, by Individual |
Material Terms of Trading Arrangement | Michael Morrissey, our Executive Vice President, Head of Global Technical Operations, adopted a trading plan on September 16, 2025 providing for the sale of up to an aggregate of 58,331 shares of our common stock until September 16, 2026.
Name | Michael Morrissey
Title | Executive Vice President, Head of Global Technical Operations
Rule 10b5-1 Arrangement Adopted | true
Adoption Date | September 16, 2025
Expiration Date | September 16, 2026
Arrangement Duration | 365 days
Aggregate Available | 58,331
Mohamed Issa [Member] |
Trading Arrangements, by Individual |
Material Terms of Trading Arrangement | Mohamed Issa, our Executive Vice President, Head of US Oncology, adopted a trading plan on September 15, 2025 providing for the sale of up to an aggregate of 11,813 shares of our common stock until September 15, 2026.
Name | Mohamed Issa
Title | Executive Vice President, Head of US Oncology
Rule 10b5-1 Arrangement Adopted | true
Adoption Date | September 15, 2025
Expiration Date | September 15, 2026
Arrangement Duration | 365 days
Aggregate Available | 11,813

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_MtrlTermsOfTrdArrTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_NonRule10b51ArrAdoptedFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_NonRule10b51ArrTrmntdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_Rule10b51ArrAdoptedFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1 + Details
Name: | ecd_Rule10b51ArrTrmntdFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TradingArrByIndTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph B + Details
Name: | ecd_TrdArrAdoptionDate
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph C + Details
Name: | ecd_TrdArrDuration
Namespace Prefix: | ecd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph C + Details
Name: | ecd_TrdArrExpirationDate
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TrdArrIndName
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph A + Details
Name: | ecd_TrdArrIndTitle
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 2 -Subparagraph D + Details
Name: | ecd_TrdArrSecuritiesAggAvailAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ecd_IndividualAxis=incy_HerveHoppenotMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=incy_StevenSteinMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=incy_LeeHeesonMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=incy_ThomasTrayMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=incy_PatrickMayesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=incy_MichaelMorrisseyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=incy_MohamedIssaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |